About Allurion
Allurion is a company based in Wellesley (United States) founded in 2009.. Allurion has raised $174.04 million across 19 funding rounds from investors including SVB, RTW Investments and Bridge Bank. The company has 137 employees as of December 31, 2024. Allurion operates in a competitive market with competitors including Apollo Endo, Sedivention, GT Metabolic Solutions, Spatz FGIA and IG Balloon, among others.
- Headquarter Wellesley, United States
- Employees 137 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Allurion Technologies, Inc.
-
Annual Revenue
$32.11 M-39.94as on Dec 31, 2024
-
Net Profit
$-7.2 M91.48as on Dec 31, 2024
-
EBITDA
$-45.25 M42.22as on Dec 31, 2024
-
Total Equity Funding
$174.04 M (USD)
in 19 rounds
-
Latest Funding Round
$5 M (USD), Post-IPO
Nov 14, 2025
-
Investors
SVB
& 9 more
-
Employee Count
137
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Allurion
Allurion is a publicly listed company on the NYSE with ticker symbol ALUR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Allurion
Allurion has successfully raised a total of $174.04M across 19 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 19
- Last Round Post-IPO — $5.0M
-
First Round
First Round
(25 Jul 2012)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Post-IPO - Allurion | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - Allurion | Valuation |
investors |
|
| Apr, 2024 | Amount | Post-IPO - Allurion | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Allurion
Allurion has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include SVB, RTW Investments and Bridge Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Investment and advisory services are provided for life sciences.
|
Founded Year | Domain | Location | |
|
Early-stage VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Allurion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Allurion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Allurion Comparisons
Competitors of Allurion
Allurion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apollo Endo, Sedivention, GT Metabolic Solutions, Spatz FGIA and IG Balloon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for obesity and GI disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a minimally invasive cryo-ablation therapy for obesity. This outpatient procedure uses cryo-ablation technology to disrupt the gastric branches of the vagus nerve, permanently reducing hunger feelings. A medical device has been developed and successfully tested for safety and efficacy. The therapy aims to provide a long-term solution for weight loss, addressing a significant unmet medical need. The company is supported by several awards and investments.
|
|
| domain | founded_year | HQ Location |
Incision-less bariatric surgery technology is developed for gastric bypass.
|
|
| domain | founded_year | HQ Location |
Minimally invasive gastric balloon is developed for obesity satiety induction.
|
|
| domain | founded_year | HQ Location |
Offers updates on medical device designs and clinical trial outcomes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Allurion
Frequently Asked Questions about Allurion
When was Allurion founded?
Allurion was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is Allurion located?
Allurion is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Is Allurion a funded company?
Allurion is a funded company, having raised a total of $174.04M across 19 funding rounds to date. The company's 1st funding round was a Post-IPO of $48M, raised on Jul 25, 2012.
How many employees does Allurion have?
As of Dec 31, 2024, the latest employee count at Allurion is 137.
What is the annual revenue of Allurion?
Annual revenue of Allurion is $32.11M as on Dec 31, 2024.
What does Allurion do?
Allurion Technologies was founded in 2009 in Wellesley, United States, focusing on medical devices in the weight management sector. The Elipse intragastric balloon is developed as a non-surgical option, swallowed via capsule and filled with liquid through a catheter. It remains in the stomach for around four months before emptying and passing naturally. The device is integrated with physician-supervised weight loss programs, avoiding endoscopy or anesthesia.
Who are the top competitors of Allurion?
Allurion's top competitors include Apollo Endo, GT Metabolic Solutions and Sedivention.
Is Allurion publicly traded?
Yes, Allurion is publicly traded on NYSE under the ticker symbol ALUR.
Who are Allurion's investors?
Allurion has 10 investors. Key investors include SVB, RTW Investments, Bridge Bank, Runway Growth Capital, and Novalis LifeSciences.
What is Allurion's ticker symbol?
The ticker symbol of Allurion is ALUR on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.